Melola Discovery

← Melola Discovery

Jurnal SINTA 1

Rosmarinic Acid from Orthosiphon aristatus Potentially Targets Estrogen Receptor-Alpha in Breast Cancer: In-silico Study

Indonesian Journal of Cancer Chemoprevention · Vol. 15 No. 2 (2024) · hlm. 150–161

DOI
10.14499/indonesianjcanchemoprev15iss2pp150-161
ISSN
2355-8989, 2088-0197
Terbit
2024-06-30
Penerbit
Indonesian Society for Cancer Chemoprevention
Bahasa
eng

Abstrak

Breast cancer is the most common cancer among women. Tamoxifen, a widely used estrogen receptor-alpha (ER-α) inhibitor, is effective but often causes side effects, necessitating the search for alternative inhibitors from natural sources. Ortosiphon aristatus, also known as cat's whiskers, is a medicinal plant traditionally valued for its anti-inflammatory and antioxidant properties. Recent studies suggest its bioactive compounds may exhibit anticancer activity by inducing apoptosis in cancer cell lines. This study explores the potential of O. aristatus metabolites as ER-α inhibitors using computational approaches. Nine metabolites were assessed for their physicochemical properties based on Lipinski’s rule of five and ADMET predictions, followed by pharmacophore-based virtual screening with LigandScout and molecular docking with AutoDock. The results showed that all tested compounds complied with Lipinski’s rule, and most met ADMET criteria. Among these, rosmarinic acid was identified as one of the hit compounds based on pharmacophore screening, exhibiting binding interactions comparable to 4-hydroxytamoxifen with the ER-α amino acid residues HIS524 and GLY521. It also demonstrated a binding energy of -8.02 kcal/mol and a low inhibition constant (Ki) of 1.31 μM. These findings highlight the potential of O. aristatus and rosmarinic acid for further evaluation as candidates against ER-α in breast cancer cells.Keywords: breast cancer, estrogen receptor-alpha, Orthosiphon aristatus, in silico.

Jaringan kolaborasi para penulis

38 penulis · 130 tautan kepenulisan bersama · 36 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Gadjah Mada
  • Padjadjaran University
  • Universitas Garut
  • Universitas Jember
  • Kementerian Kesehatan Republik Indonesia
  • Nara Institute of Science and Technology
  • Indonesian Institute of Sciences
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Edy MeiyantoUniversitas Gadjah Mada4
Riris Istighfari JenieUniversitas Gadjah Mada2
Nunuk PurwantiUniversitas Gadjah Mada1
Banun KusumawardaniUniversitas Jember1
Dwi Merry Christmarini RobinUniversitas Gadjah Mada1
Retno ArdhaniUniversitas Gadjah Mada1
Faaza Aulia RahmanUniversitas Gadjah Mada1
Adam HermawanUniversitas Gadjah Mada1
Laeli MuntafiahUniversitas Gadjah Mada1
Nur Fitra SariUniversitas Gadjah Mada1
Muchtaridi MuchtaridiPadjadjaran University1
Nawadhir FauzanPadjadjaran University1
Riska PrasetiawatiUniversitas Garut1
Meilia SuhermanUniversitas Garut1
Ediati SasmitoUniversitas Gadjah Mada1
Sari HaryantiKementerian Kesehatan Republik Indonesia1
Herwandhani PutriUniversitas Gadjah Mada1
Beni LestariUniversitas Gadjah Mada1
Jun‐ya KatoNara Institute of Science and Technology1
Retno MurwantiUniversitas Gadjah Mada1
Devyanto Hadi TriutomoUniversitas Gadjah Mada1
Fitriana Hayyu ArifahUniversitas Gadjah Mada1
Anselma IvanawatiUniversitas Gadjah Mada1
Zahrotul UlumUniversitas Gadjah Mada1
Sri HandayaniIndonesian Institute of Sciences1
Dzava Prawinsyah Fairus IsmailAfiliasi tidak diketahui1
Najla Yasmintia WidarsoPadjadjaran University1
Ari Anggi MahwatiPadjadjaran University1
Irene Ivory SibueaPadjadjaran University1
Bintang Satrio MahardikaPadjadjaran University1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://ijcc.chemoprev.org/index.php/ijcc/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Rosmarinic Acid from Orthosiphon aristatus Potentially Targets Estrogen Receptor-Alpha in Breast Cancer: In-silico Study</dc:title>
	<dc:creator>Qurrotaayun, Ghina Alya Putri</dc:creator>
	<dc:creator>Sitompul, Joy Elizabeth Nauli</dc:creator>
	<dc:creator>Fadhilah, Naya</dc:creator>
	<dc:creator>Pramudita, Fransisca Widi</dc:creator>
	<dc:creator>Putri, Nazwa Septiriana</dc:creator>
	<dc:creator>Muljono, Fajar Oktavian</dc:creator>
	<dc:creator>Fardhan, Firghi Muhammad</dc:creator>
	<dc:creator>Novitasari, Dhania</dc:creator>
	<dc:description xml:lang="en-US">Breast cancer is the most common cancer among women. Tamoxifen, a widely used estrogen receptor-alpha (ER-α) inhibitor, is effective but often causes side effects, necessitating the search for alternative inhibitors from natural sources. Ortosiphon aristatus, also known as cat's whiskers, is a medicinal plant traditionally valued for its anti-inflammatory and antioxidant properties. Recent studies suggest its bioactive compounds may exhibit anticancer activity by inducing apoptosis in cancer cell lines. This study explores the potential of O. aristatus metabolites as ER-α inhibitors using computational approaches. Nine metabolites were assessed for their physicochemical properties based on Lipinski’s rule of five and ADMET predictions, followed by pharmacophore-based virtual screening with LigandScout and molecular docking with AutoDock. The results showed that all tested compounds complied with Lipinski’s rule, and most met ADMET criteria. Among these, rosmarinic acid was identified as one of the hit compounds based on pharmacophore screening, exhibiting binding interactions comparable to 4-hydroxytamoxifen with the ER-α amino acid residues HIS524 and GLY521. It also demonstrated a binding energy of -8.02 kcal/mol and a low inhibition constant (Ki) of 1.31 μM. These findings highlight the potential of O. aristatus and rosmarinic acid for further evaluation as candidates against ER-α in breast cancer cells.Keywords: breast cancer, estrogen receptor-alpha, Orthosiphon aristatus, in silico.</dc:description>
	<dc:publisher xml:lang="en-US">Indonesian Society for Cancer Chemoprevention</dc:publisher>
	<dc:contributor xml:lang="en-US"></dc:contributor>
	<dc:date>2024-06-30</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US"></dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://ijcc.chemoprev.org/index.php/ijcc/article/view/510</dc:identifier>
	<dc:identifier>10.14499/indonesianjcanchemoprev15iss2pp150-161</dc:identifier>
	<dc:source xml:lang="en-US">Indonesian Journal of Cancer Chemoprevention; Vol 15, No 2 (2024); 150-161</dc:source>
	<dc:source>2355-8989</dc:source>
	<dc:source>2088-0197</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://ijcc.chemoprev.org/index.php/ijcc/article/view/510/306</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2024 Indonesian Journal of Cancer Chemoprevention</dc:rights>
</oai_dc:dc>